Start 30 days free, no card. Full Pro access for a month, then decide. Start free

Back to analysts list

Analyst

Bonnie Herzog

Goldman Sachs · covers Consumer Defensive, Consumer Cyclical

Period: Reporting periods mapped to calendar 2024 Q3 – 2026 Q3 (9 quarters).

Questions
125on tracked calls
Challenge rate
26%33 of 125 questions
Companies
18questioned at least once
Reporting periods
9with questions

These figures cover the whole profile: every tracked question, all reporting periods.

How to read these numbers

Challenge rate is the share of questions that pushed back, pressed for specifics or questioned management’s assumptions. It describes how questions were asked on the calls tracked here; it does not measure whether any view turned out to be right.

Rounding. Rates are rounded to whole percentages, so a small share can show as 0% even when some questions were challenging. The count beside each rate is exact; “none of N questions” means no question was challenging.

No questions recorded. “—” means there is nothing to calculate: no questions were recorded for that period on the calls tracked here. It does not mean there was no activity.

Fewer than 3 questions. A company-level rate is withheld when fewer than 3 questions were recorded for that company; the questions are still counted everywhere else.

Small samples. Profiles with fewer than 10 questions are marked Limited sample.

Reporting periods. Questions are grouped by the calendar quarter each company’s fiscal reporting period maps to, not by the date of the call. Periods without a calendar mapping are listed separately under their fiscal label.

Questions asked

Grouped by company, most questions first. Open a company to read its questions, newest reporting period first.

Showing 125 of 125 questions from 18 companies

PMPhilip Morris International15 questions · 7 reporting periods · 2 of 15 challenging
PM company page →

Calendar 2026 Q2

should we anticipate a big step-up in promotional spend behind ZYN?

Capital AllocationGuidance ReliabilityTranscript · FY2026 Q2 →
Show response

Babeau tied held guidance to stepped-up US investment (broader portfolio, When it Clicks campaign, MRTP) but declined specifics on any price or promo action, citing competitive sensitivity.

a little more color on the rollout of ZYN Ultra, early feedback you've been hearing from retailers and consumers

Product LaunchDemandTranscript · FY2026 Q2 →
Show response

Babeau flagged encouraging first two weeks of ZYN Ultra offtake and share gains but urged caution given the short window, and positioned 1.5mg as key to converting smokers.

Calendar 2026 Q1

You did mention you expect performance to improve over the course of the year. So maybe I'd like to better understand what gives you the confidence

DemandRegulation PolicyProduct LaunchTranscript · FY2026 Q1 →
Show response

CEO outlined H2 improvement drivers: normalizing comps on revenue per can, underlying shipment base, and innovation launches. Declined to specify innovation timing or comment on launching without FDA approval.

Your Q1 results came in better than your expectations. And a key driver of this really was the strength behind IQOS

Revenue GrowthProduct LaunchCompetitive DynamicsTranscript · FY2026 Q1 →
Show response

CEO emphasized IQOS brand differentiation and 75% category share as structural drivers. Highlighted Italy's return to double-digit growth post flavor ban and Taiwan's rapid adoption as proof of brand strength.

Calendar 2025 Q4

hoping you could talk a little bit more about the elasticities you're expecting, you know, with volumes I assume being pretty negatively impacted?

PricingRegulation PolicyTranscript · FY2025 Q4 →
Show response

Olczak acknowledged volume impact from April and October excise steps but declined to detail pricing strategy, noting margin expansion may take longer than immediate but expressing confidence in eventual delivery.

Could you maybe frame for us or touch on the key growth drivers that really will allow you to deliver on your top and bottom-line guidance and possibly beat it

Guidance ReliabilityCapex InvestmentTranscript · FY2025 Q4 →
Show response

Emmanuel confirmed same fundamental growth model with positive smoke-free mix and combustible resilience. Specific 2026 headwinds are Japan excise, US ZYN base comparison, and Turkey/India/Mexico combustible volume pressure.

Calendar 2025 Q3

I also want to understand the drivers behind your full year dollar EPS growth guidance raise despite the lower operating income growth guidance What are the drivers below the line?

ChallengingGuidance ReliabilityRevenue GrowthTranscript · FY2025 Q3 →
Show response

Emmanuel attributed EPS guidance raise to favorable tax rate trends and better-than-expected interest costs, on top of the strong OI growth engine. Noted OI could still finish above 11%.

The stepped-up investments in The U.S, is this all Zen related or are you also accelerating spend behind IQOS or the full planned, you know, rollout of Illumina?

Capex InvestmentProduct LaunchTranscript · FY2025 Q3 →
Show response

Emmanuel confirmed investment spans both ZYN commercial support and IQOS launch preparation, including team-building and state-level presence, with spending continuing into 2026.

Did it actually bring in new consumers to the brand? And if so, I mean, can you give us a sense of what percentage of the free can promo resulted in new consumers to the brand?

DemandCompetitive DynamicsTranscript · FY2025 Q3 →
Show response

Emmanuel declined to quantify new consumer conversion rate but confirmed early feedback is 'extremely positive' with 80% of free can recipients being smokers/vapers, indicating successful recruitment targeting.

Calendar 2025 Q2

How does that change your strategy, you know, as it relates for Zen, as it relates to, you know, your pricing, promotions

PricingCompetitive DynamicsTranscript · FY2025 Q2 →
Show response

Emmanuel confirmed full 360-degree restart of commercial activities: increased promotions (though still below competitors), advertising, point-of-sale activity, brand building, and smoker/vaper acquisition programs.

should we assume lower end of your full year shipment guidance range is more realistic?

ChallengingDemandGuidance ReliabilityTranscript · FY2025 Q2 →
Show response

Emmanuel defended the full 800-840M can range, noting the 10-20M lower restocking is offset by ZYN's powerful restart at 36-37% offtake growth, with commercial activity restarting.

Calendar 2025 Q1

Could you maybe give us some more color on the out-of-stock issues you might still be experiencing in the U.S.?

Supply ChainDemandTranscript · FY2025 Q1 →
Show response

Emmanuel outlined gradual ZYN restocking through Q2-Q3, with normalized supply expected by Q3. Shipment profile will show accelerating growth reflecting both consumer offtake acceleration and replenishment.

how should we think about the drivers of continued margin expansion for the remaining of the year?

MarginCompetitive DynamicsTranscript · FY2025 Q1 →
Show response

Emmanuel highlighted ZYN US as best-in-class margin, IQOS scale benefits, 3% smoke-free pricing, and consistent IQOS gross margin improvement over 2-3 years. Smoke-free margin gap vs combustible expected to persist.

Calendar 2024 Q4

you continue to target gross margin expansion in combustibles, And then you did say that you expect the gap to grow

MarginCompetitive DynamicsTranscript · FY2024 Q4 →
Show response

Emmanuel confirmed the gap between smoke-free and combustible margins could continue to expand, driven by both combustible improvement and rapid smoke-free progress.

hoping you could highlight the, you know, some of the key drivers behind this

MarginProduct LaunchTranscript · FY2024 Q4 →
Show response

Jacek outlined margin drivers including pricing, positive smoke-free mix, easing COGS headwinds, and IQOS device scale. US IQOS ILUMA expected 2-3 years to net positive contribution.

MOAltria14 questions · 7 reporting periods · 6 of 14 challenging
MO company page →

Calendar 2026 Q2

I'm hoping for a little bit more color on why you didn't recognize more of a benefit in Q2

MarginGuidance ReliabilityTranscript · FY2026 Q2 →
Show response

Newman named both components, credit application timing and product staging, and reaffirmed a more balanced Q3/Q4 benefit.

cig volume declines are moderating. So just maybe hoping for a little bit more color on what you think might be driving

DemandMacroeconomicTranscript · FY2026 Q2 →
Show response

Mancuso broke the decline into secular, elasticity and cross-category buckets and acknowledged Basic comps will be lapped, while declining to forecast volumes.

Calendar 2026 Q1

how you're going to manage Kiboycut relative to say Marlboro Black in terms of pricing?

PricingProduct LaunchTranscript · FY2026 Q1 →
Show response

Sal framed Cowboy Cut as an RGM tool offering price-sensitive Marlboro consumers an option, with distribution expanding later in Q2.

should we expect a steady increase in the benefit each quarter as the year progresses?

MarginGuidance ReliabilityTranscript · FY2026 Q1 →
Show response

Sal confirmed export volume and duty drawback benefits build through the year, but balanced 1H/2H growth is driven mainly by cross-category moderation.

Calendar 2025 Q4

your retail share on the brand did drop below 40% for the first time, I think ever. So how are you thinking about your strategy behind Marlboro

ChallengingCompetitive DynamicsDemandTranscript · FY2025 Q4 →
Show response

Billy attributed Q4 share drop partly to enforcement reducing illicit vape availability, pushing dual-use consumers back to cigarettes where they chose discount. Analytics show Basic is not cannibalizing Marlboro.

is it fair to assume your aggressive promotional strategy behind Basic, which is weighing on your net price realization

ChallengingPricingCompetitive DynamicsTranscript · FY2025 Q4 →
Show response

Billy firmly separated Basic and duty drawback strategies. Basic targets approximately 30,000 stores where consumers face severe economic pressure. It captures consumers before they go to deep discount.

Calendar 2025 Q3

could you touch on what you're seeing and whether I guess you've been happy with the performance and positioning of on!

ChallengingCompetitive DynamicsProduct LaunchTranscript · FY2025 Q3 →
Show response

Billy highlighted on! was raising prices while category dropped 7% nationally and over 70% at one major retailer. Pleased with retail takeaway stability. Too early on on! PLUS.

just hoping for a little more color on the operational efficiencies you see, especially as it relates to opportunities

Geographic ExpansionM&ATranscript · FY2025 Q3 →
Show response

Billy outlined three-pronged partnership: international modern oral expansion with LOOP, U.S. non-nicotine through Korean red ginseng, and manufacturing efficiencies enabling duty drawback.

Calendar 2025 Q2

how are you feeling about your ability to deliver on your long-term EPS growth algo of mid-single digits through FY '28

ChallengingGuidance ReliabilityTranscript · FY2025 Q2 →
Show response

Billy reaffirmed mid-single digit CAGR goal. Noted consumer under strain but making disciplined moves. Consumers adjusting if conditions stay stagnant.

Could you talk a little bit more about your strategy with the brand and the changes you've made to your promotions on the brand

PricingCompetitive DynamicsTranscript · FY2025 Q2 →
Show response

Billy framed Basic repositioning as cyclical rotation of discount brands. Data analytics enable targeted approach in approximately 30,000 stores. Finds it cheaper to keep consumers in portfolio.

Calendar 2025 Q1

I'm curious to hear why you're no longer providing this in your metric sheet

ChallengingPricingCompetitive DynamicsTranscript · FY2025 Q1 →
Show response

Billy explained national price gap metric was causing confusion since business is managed at store level. Marlboro Black in some stores had price gap as low as 5%.

how concerned you are and are further share gains factored into the low end of your guidance

ChallengingRevenue GrowthGuidance ReliabilityTranscript · FY2025 Q1 →
Show response

Billy reiterated long-term profitability strategy. Emphasized strength of Marlboro, RGM tools for consumer relief, and monitoring of tariff impacts on consumers.

Calendar 2024 Q4

your guidance includes the likely potential you're going to have to pull NJOY ACE from the market

Guidance ReliabilityTranscript · FY2024 Q4 →
Show response

Sal confirmed multiple scenarios were modeled but did not explicitly address whether NJOY ACE removal could boost the high end of guidance.

you could provide a little more color on the possible options you have for NJOY

Regulation PolicyCompetitive DynamicsTranscript · FY2024 Q4 →
Show response

Billy outlined multiple pathways including USTR review and SE exemptions for three patents. Emphasized discipline on settlement given pod segment declining roughly 15%.

CASYCasey's General Stores, Inc.11 questions · 8 reporting periods · 1 of 11 challenging
CASY company page →

Calendar 2026 Q3

could you provide a little more color on the FQ1 drivers? And how you expect the cadence for OpEx to trend from here?

Cost PressureMarginTranscript · FY2027 Q1 →
Show response

Steve broke down the 8% OpEx increase: about 1pt employee expense, 2pts same-store operations, 2pts new units and 1.5pts credit card fees, and reaffirmed growing OpEx slower than EBITDA long term.

Calendar 2026 Q2

what gives you the confidence to be able to generate this growth, especially considering the tough comps from last year?

Guidance ReliabilityMarginTranscript · FY2026 Q4 →
Show response

Steve grounded the 8-10% EBITDA guide in a roughly even split between mothership margin/velocity gains and new-unit contribution.

Calendar 2026 Q1

I was hoping you could touch on the durability of your new unit growth, I guess, over the long term.

Capex InvestmentGuidance ReliabilityTranscript · FY2026 Q3 →
Show response

Darren confirmed on track for 80 stores and 500 over 3-year plan (originally 350, raised to 500). Sustainable algorithm is ~4% unit growth per year. NTI pipeline extends to FY28-29. Pulled back this year deliberately for CEFCO integration.

Calendar 2025 Q4

Can you just remind us your M&A strategy, where you're at and sort of what the market is like right now?

M&ACapex InvestmentTranscript · FY2026 Q2 →
Show response

Darren said no change to M&A strategy. Small tuck-in deals normal course with dedicated team. Larger deals opportunistic. High bar on asset quality (must accommodate kitchens). Will say no to more than they say yes to.

your guidance does still imply a sequential deceleration in EBITDA growth in the second half. So just hoping to hear some of the drivers of that.

Guidance ReliabilityM&ATranscript · FY2026 Q2 →
Show response

Steve said purely mechanical: Fikes now in prior year base, so year-over-year growth rate steps down. No change in expectations for mothership or Fikes performance. Just math of comping a higher base.

Calendar 2025 Q3

could you maybe quantify your spend levels this quarter versus the prior quarter and then maybe year-over-year?

Competitive DynamicsPricingTranscript · FY2026 Q1 →
Show response

Steve noted majority of promotions (BOGOs etc.) are vendor-funded and don't show directly in financials. Absolute promo level up with more stores, but company's direct spend not quantified.

love to hear how the quarter came in maybe relative to your internal expectations? And then I guess if it was a little bit stronger, does it suggest maybe some conservatism to your guidance this year?

Guidance ReliabilityRevenue GrowthTranscript · FY2026 Q1 →
Show response

Darren and Steve declined to comment on internal expectations or guidance conservatism, reiterating they will update at Q2. Steve reminded that Fikes comping effects make H1/H2 total growth look different.

Calendar 2025 Q2

I guess I'm hoping to hear a little bit more color on your inside sales for the full year of FY '25, which I guess, fell a little short of your lowered full year guidance.

ChallengingDemandRevenue GrowthTranscript · FY2025 Q4 →
Show response

Darren cited softer Q1 start plus February weather/leap day (-300bp to Feb comps). March came back at 3.7%, April at 5%, May in guidance range. Illicit vape hurting vape category but offset by nicotine alternatives up 54%.

Calendar 2025 Q1

just hoping you could touch on how your business model and value proposition might position you hopefully well in the case of a recessionary environment

MacroeconomicCompetitive DynamicsTranscript · FY2025 Q3 →
Show response

Darren noted Casey's sells basic daily needs at low price points, offers QSR trade-down on food without quality sacrifice, and has not increased promotional spend but is more targeted.

Calendar 2024 Q4

are you seeing any change behavior, consumer behavior, are you seeing any strengthening with the consumer in the context of all of this?

DemandMacroeconomicTranscript · FY2025 Q2 →
Show response

Darren said consumer trends directionally unchanged, lower income consumers still soft but 75% of customers shopping normally at same frequency.

Same-store inside sales guidance of 3% to 5% for the year, which you maintained, I guess at the midpoint this does imply a bit of an acceleration

Revenue GrowthDemandTranscript · FY2025 Q2 →
Show response

Steve confirmed November at 4% (midpoint of guidance), traffic was positive in Q2, and Q4 leap day lap is already factored in. No need to change range.

PEPPepsiCo9 questions · 8 reporting periods · 3 of 9 challenging
PEP company page →

Calendar 2026 Q3

Curious if you would consider accelerating SKU rationalization on some of the underperforming brands in that business

Product LaunchCompetitive DynamicsM&ATranscript · FY2026 Q3 →
Show response

Laguarta defended the portfolio (portion-control and permissible platforms) and left room for tuck-in M&A, but did not address SKU rationalization directly.

Calendar 2026 Q2

Your volume was flat in the quarter, despite what seems to be stepped up affordability initiatives

ChallengingDemandPricingRevenue GrowthTranscript · FY2026 Q2 →
Show response

Laguarta reframed to company-wide 7% H1 revenue and volume gains, credited affordability plus permissible/portion-control, but flagged H2 ROI optimization on pricing investments.

Calendar 2026 Q1

what's continuing to pressure volumes and maybe your strategy to drive better volume growth this year

ChallengingDemandRevenue GrowthCompetitive DynamicsTranscript · FY2026 Q1 →
Show response

Ramon attributed volume pressure to the case-pack-water third-party transition with only 1 more month to lap, and pointed to the 9% total business growth including new platforms.

you still expect to deliver both organic revenue growth and core operating margin expansion this year for the business

MarginRevenue GrowthTranscript · FY2026 Q1 →
Show response

Steve acknowledged the prior-year comp issue but pivoted to managing margin at the total company level, emphasizing flexibility rather than committing to segment-level margin expansion.

Calendar 2025 Q4

how you'll ultimately balance growth and profitability for that business

PricingMarginDemandTranscript · FY2025 Q4 →
Show response

Steve said investments manageable and funded by Q4 productivity carryover; Ramon added it's surgical, tested at scale in key markets since Q2 last year with very good ROI.

Calendar 2025 Q3

can you give us a sense of how much this is being impacted by your pivot to smaller pack sizes

Show response

Ravi Pamnani answered, explaining beverages grew volume ex-case pack water; food volume impacted by promo strategy shift from deep single-brand to everyday low value across all brands. Service levels now at 97-98%.

Calendar 2025 Q2

could you quantify the productivity savings you're hoping to generate this year? And how much above the typical $1 billion run rate it will be

Cost PressureMarginTranscript · FY2025 Q2 →
Show response

Jamie detailed plant closures, line shutdowns, workforce rightsizing, procurement savings from ERP, and operating model changes. Ramon framed as multi-year productivity across standalone, NA integration, and global capability centers.

Calendar 2025 Q1

how some of those investments are paying off? And then, if you're making any changes to your strategy, especially given the pressured consumer environment

Show response

Ramon described three-pillar strategy executing as planned: value investments showing early returns in dual-size single serve and 10-count multi-packs, portfolio transformation, and operational excellence.

Calendar 2024 Q4

Your EPS guidance assumes some leverage, but not nearly as much as you've reported in prior years

ChallengingGuidance ReliabilityMarginTranscript · FY2024 Q4 →
Show response

Ramon acknowledged caution due to geopolitical volatility; Jamie added 3pt FX headwind and higher below-the-line costs from debt and pensions as factors compressing EPS leverage.

STZConstellation Brands9 questions · 9 reporting periods · 2 of 9 challenging
STZ company page →

Calendar 2026 Q3

I am ultimately wondering, what should we expect for the pace of buybacks?

Capital AllocationM&ATranscript · FY2027 Q2 →
Show response

Hankinson cited $530 million repurchased year-to-date and $2.5 billion remaining, promising programmatic and opportunistic buybacks but no specific pace.

Calendar 2026 Q2

You maintained your beer net sales guidance despite strong shipments in the quarter

Guidance ReliabilityDemandTranscript · FY2027 Q1 →
Show response

Hankinson attributed maintained guidance to low macro visibility and gas-price volatility, not specific shipment headwinds.

Calendar 2026 Q1

Your guiding margins of 37% to 38% for this year, which is a step down from your prior guidance of 39% to 40%

ChallengingMarginCapex InvestmentTranscript · FY2026 Q4 →
Show response

Garth cited Veracruz fixed cost absorption as primary margin headwind, plus SG&A increase from lower FY26 incentive comp baseline and incremental marketing investment. Offset by 1-2% pricing (lower end), cost savings, and aluminum tariff relief.

Calendar 2025 Q4

They came in a lot stronger than expected in the quarter despite the volume deleverage

MarginCost PressureTranscript · FY2026 Q3 →
Show response

Garth cited Q3 margin tailwinds: cost savings, pricing actions, depreciation timing benefit. Q4 headwinds: lowest seasonal quarter (20% of volume), depreciation reversal, rising aluminum tariff impact, and expense timing shift from Q3 to Q4.

Calendar 2025 Q3

I'd love to hear more color on the beer op margin expansion in the quarter, I guess, as well as key headwinds to margins in the back half

MarginCost PressureTranscript · FY2026 Q2 →
Show response

Garth detailed H2 headwinds: 100bps fixed costs, 60bps incremental margin pressure, partially offset by lower comp and benefits. H2 always lower margin due to seasonality and brewery maintenance.

Calendar 2025 Q2

Could you give us some color on what is happening with the rebuild? And what type of growth or upside you might be expecting from this

DemandMacroeconomicTranscript · FY2026 Q1 →
Show response

Garth noted rebuild creates beer occasions through construction jobs, confirmed tailwind is built into guidance. Joe Suarez tempered by noting California construction employment still down YoY and Hispanic unemployment elevated.

Calendar 2025 Q1

what are you assuming for the beer category growth or I guess declines over the next few years

Show response

Bill expects beer category flat to -2%, with STZ continuing to gain significant share. Garth reiterated 39-40% beer margin framework unchanged, citing modular CapEx, cost savings, 1-2% pricing offsetting inflation and tariffs.

Calendar 2024 Q4

while you lowered your full year beer net sales growth guidance, which makes sense, you actually widened the range and there are only 2 months left in the year

ChallengingGuidance ReliabilityMacroeconomicTranscript · FY2025 Q3 →
Show response

Bill cited high volatility vs historical trends as reason for wider range, noted California fire impact already factored into guidance.

Calendar 2024 Q3

curious to hear if the lift from that has met your expectations. And then also, any color on potential shelf space gains

Competitive DynamicsDemandTranscript · FY2025 Q2 →
Show response

Bill highlighted double-digit shelf gains in spring resets and increased marketing investment funded by above-plan cost savings.

CLXClorox8 questions · 7 reporting periods · 2 of 8 challenging
CLX company page →

Calendar 2026 Q2

I'm wondering why your range is, I guess, relatively wide versus the tight guidance range on sales

Guidance ReliabilityMarginTranscript · FY2026 Q4 →
Show response

Luc attributed the wide EPS range to gross-margin sensitivity and cost/commodity timing rather than giving explicit bottom/top scenarios.

Calendar 2025 Q4

Organic sales, you know, remain quite pressured, you know, just up promotions behind trash and litter as you, you know, you highlighted. But you know, if I look at it that way, then I see the press...

ChallengingMarginCompetitive DynamicsTranscript · FY2026 Q2 →
Show response

Linda said strategy is doubling down on innovation (Glad Leakguard, full Litter relaunch) rather than purely promotional. Being disciplined on price promotion, consumers don't use more trash bags at lower prices. Short-term selective investment while maintaining long-term category value. Holistic margin management funds investments. Last 12 months not best performance but right plans moving forward.

Calendar 2025 Q3

just hoping for a little bit more color on the puts and takes of that. You highlighted your current expectations are to be at the lower end of the range.

Guidance ReliabilityRevenue GrowthTranscript · FY2026 Q1 →
Show response

Luc said wide range deliberate for agility. High end requires: categories at 1%+, great innovation execution, no supply disruptions. ERP inventory estimate finalized at 7.5pts (from 7-8 range). Feels good about retailer inventory positioning at end of Q1.

Calendar 2025 Q2

Was there a greater build in certain businesses or segments versus others?

Capex InvestmentDemandTranscript · FY2025 Q4 →
Show response

Linda said no material ERP segment difference except international (lower due to export size). Kingsford underperformed due to execution: less merchandising on wrong sizes for Memorial Day, not a price gap issue. Adjusted for July 4, saw improvement. Making further adjustments for Labor Day.

Calendar 2025 Q1

how does the current demand backdrop impact your shipments and then the inventory build out? I guess I'm trying to understand why you're now expecting a greater lift on organic sales from the trans...

Capex InvestmentMarginTranscript · FY2025 Q3 →
Show response

Luc said retailers building 1.5 weeks of inventory. 1-2 days variability equals 1-2 points of growth. Vast majority of reversal in Q1 FY2026. Linda added retailers committed to pre-build regardless of demand environment to avoid consumer out-of-stocks.

Calendar 2024 Q4

could you talk about your sourcing exposure from some of the impacted regions? I guess, which part of your business do you see the most potential impact?

Trade TariffsSupply ChainTranscript · FY2025 Q2 →
Show response

Kevin said tariffs not baked into outlook. Short supply chains, near-shored/on-shored production over recent years reduces exposure. Already taken actions to minimize. Very dynamic environment.

Is it to avoid any potential risk that they can't get the product that they need? Is there some concern on your side just given the transition that you want to ship ahead of consumption

Capex InvestmentSupply ChainTranscript · FY2025 Q2 →
Show response

Linda said this is standard for any ERP transition. Built retailer inventories to cover system shutdown/bring-up period. Well within normal benchmarks from peers. Goal is zero consumer impact.

Calendar 2024 Q3

I'd love to hear if you believe you're getting the appropriate lift on your promotional spend, and if not, do you have plans to modify your strategy

ChallengingCompetitive DynamicsPricingTranscript · FY2025 Q1 →
Show response

Linda rejected prisoner's dilemma concern. Said Litter has natural category tailwinds and innovation historically reinvents the category. Current promo is strategic and temporary.

Show 12 more companies
CHDChurch & Dwight7 questions · 5 reporting periods · 2 of 7 challenging
CHD company page →

Calendar 2026 Q2

how much further you plan to step up reinvestments to drive sustainable top line growth ahead?

Capital AllocationGuidance ReliabilityTranscript · FY2026 Q2 →
Show response

Rick pointed to CHD's track record of reinvesting outperformance into marketing and new AI initiatives rather than dropping it to EPS.

Calendar 2025 Q4

They've really been elevated in a lot of the HPC categories, and we're seeing a fair amount of negativity on price mix

ChallengingPricingCompetitive DynamicsTranscript · FY2025 Q4 →
Show response

CEO emphasized brands matter more than promotions. ARM & HAMMER only brand gaining laundry share while spending below category. Expects promotional levels to drift back to normalcy.

Calendar 2025 Q3

your volume growth was quite strong in the quarter, but price/mix was slightly negative. So I guess just could you kind of drill down on what sort of drove that?

PricingCompetitive DynamicsTranscript · FY2025 Q3 →
Show response

CEO explained litter promotions at near all-time 24% high from one competitor. Negative price/mix driven by BATISTE value adjustments, vitamin pricing, and consumer shift to larger sizes.

Could you give us a sense of maybe how the brand has been performing in the different channels, DTC and then certainly at Sephora

M&ARevenue GrowthGeographic ExpansionTranscript · FY2025 Q3 →
Show response

CEO confirmed ~90% of TOUCHLAND at Sephora/Ulta/Amazon with no plans to broadly change strategy. International expansion exciting, already seeing fast growth in Canada. Will discuss more in January.

Calendar 2025 Q2

Could you just maybe touch on the puts and takes, including tariffs on the expected declines on gross margins, especially in Q3?

MarginTrade TariffsCost PressureTranscript · FY2025 Q2 →
Show response

CFO explained 20-30bps of tariff cost shifted from Q2 to Q3 due to evolving rates/shipment timing. Productivity still strong, inflation remains sticky. Full year gross margin contraction still -60bps.

We've seen increased couponing activity across broader HPC and then scanner data is suggesting that sales on promotions have been rising

ChallengingPricingCompetitive DynamicsTranscript · FY2025 Q2 →
Show response

CEO noted divergent story: Litter promotions spiked to 21% (vs 15-18% historical) driven by Nestle lightweight litter push, while Laundry remains in low 30s consistent with recent quarters.

Calendar 2024 Q4

hoping for a little more color on the differences of growth that you’re seeing in Global Markets group versus the subsidiaries

Revenue GrowthDemandTranscript · FY2024 Q4 →
Show response

Dierker expressed broad-based international excitement spanning brands and geographies, noting the company is 20 years behind most CPG peers on international development. Read detailed growth across mature subs (Canada, France), newer subs with double-digit growth (Germany, Mexico), and LatAm/Eastern Europe standouts in GMG.

CLColgate-Palmolive7 questions · 7 reporting periods · 4 of 7 challenging
CL company page →

Calendar 2026 Q2

How should we think about the cadence of growth for the rest of the year?

DemandGuidance ReliabilityTranscript · FY2026 Q2 →
Show response

Noel declined to specify back-half organic but pointed to the private-label exit lapping and emerging-market strength as tailwinds against U.S. pressure.

Calendar 2026 Q1

You maintained your top and bottom line guidance, but you highlighted gross margins will be more pressured

ChallengingMarginPricingGuidance ReliabilityTranscript · FY2026 Q1 →
Show response

Noel confirmed comfort with low to mid-single-digit EPS range, cited RGM efforts, premium innovation-led pricing, price pack architectures, and SGPP as offsets. Acknowledged margins likely down for the year.

Calendar 2025 Q4

curious if the decision to spend more on A&P this year is because you want to improve your market share in certain categories

Capital AllocationCompetitive DynamicsGuidance ReliabilityTranscript · FY2025 Q4 →
Show response

Wallace explained omni demand generation capabilities driving efficiency gains. Dollar ad spend up 5% YoY despite percent of sales decline. Focus on optimization and efficiency while selectively increasing in high-return areas.

Calendar 2025 Q3

guidance assumes a step-up in Q4 at the midpoint

ChallengingGuidance ReliabilityRevenue GrowthTranscript · FY2025 Q3 →
Show response

Sutula noted Q4 needs improvement over Q3 to hit ~1.2% full year. Drivers: Total impact easing, destocking normalizing. Private label drag roughly same as Q3. Momentum provides confidence.

Calendar 2025 Q2

what gives you the confidence in your low single-digit EPS growth expectation this year

ChallengingGuidance ReliabilityMarginTranscript · FY2025 Q2 →
Show response

Wallace cited strategy working with good H2 investment and innovation pipeline. Sutula noted tariff reduction and FX benefit offset by slower organic and higher raw materials, balancing out.

Calendar 2025 Q1

You updated the guide to flat spending as a percent of sales for the year versus flat to slightly previously

ChallengingCapital AllocationProduct LaunchTranscript · FY2025 Q1 →
Show response

Wallace denied any innovation pullback, noting acceleration discussions. Revision driven by spending optimization and prudent P&L flexibility. Local currency ad spend still up.

Calendar 2024 Q4

how should we think about the contribution from price versus volume mix in North America

PricingDemandCompetitive DynamicsTranscript · FY2024 Q4 →
Show response

Wallace noted price adjustments from Q2 will taper in back half of 2025. Oral, Personal and Home Care performed well ex-skin. Green shoots in toothpaste, liquid hand soap, and dish.

MNSTMonster Beverage7 questions · 7 reporting periods · 1 of 7 challenging
MNST company page →

Calendar 2026 Q2

should we think about per case operating expenses in Q2 as a good run rate, or could this move lower

Cost PressureMarginTranscript · FY2026 Q2 →
Show response

Hilton attributed the step-up to higher freight and fuel plus expanded 2026 marketing (Formula One, Morgan Wallen tour, UFC, Unleash the Beast campaign) aimed at the new, younger consumer.

Calendar 2026 Q1

just hoping for a little more color on what's driving the strong demand

DemandSupply ChainTranscript · FY2026 Q1 →
Show response

Hilton confirmed they are back within orbits and the out-of-orbit production was a Q1-specific issue driven by demand exceeding forecasts. No indication of pull-forward given strong April sales.

Calendar 2025 Q4

Would you consider further pricing actions to offset the cost pressures?

PricingProduct LaunchTranscript · FY2025 Q4 →
Show response

CEO confirmed ongoing pricing review. November pricing went according to plan with no volume falloff. Innovation staggered across H1 with fall launches planned. America250 LTOs rolling out to select retailers.

Calendar 2025 Q3

I think they came in better than you expected since I believe you suggested to us last quarter that they would decline sequentially

Show response

CEO noted gross margin flat QoQ was pleasing. Three positive drivers: pricing, supply chain optimization, and product mix shift toward zero sugar. Expects modest tariff impact in Q4 and Q1 2026, offset by pricing benefits starting November.

Calendar 2025 Q2

Question on that just in terms of your supply chain optimization efforts because Hilton, I know you've been working on that

Supply ChainDemandTranscript · FY2025 Q2 →
Show response

CEO explained Phoenix facility at ~10% of US sales with well-balanced co-packing model delivering lowest landed cost. On category drivers: competitive CSD pricing, functionality appeal, move away from alcohol, and strong innovation pipeline.

Calendar 2025 Q1

I'd be curious to hear, how much lower were your reported sales during the quarter versus maybe your internal expectations?

ChallengingRevenue GrowthProduct LaunchTranscript · FY2025 Q1 →
Show response

Management did not quantify the shortfall vs internal expectations. On innovation, noted Q1 had more launches than Q2, with Blue Hawaiian and Vice Guava getting to shelves faster than typical. More innovation planned for fall.

Calendar 2024 Q4

Could you give us a little more color on the drivers behind the expansion? I guess I'm curious how much did the price increase on November 1 help

MarginPricingTrade TariffsTranscript · FY2024 Q4 →
Show response

Co-CEO explained reduced input costs drove margins, pricing helped but was offset by commercial allowances. Called tariff discussion premature but noted nice aluminum hedges for 2025.

KOThe Coca-Cola Company6 questions · 6 reporting periods · 1 of 6 challenging
KO company page →

Calendar 2026 Q2

I just had a quick question on your updated guidance, which does now imply more bottom line leverage for the year.

Guidance ReliabilityMarginTranscript · FY2026 Q2 →
Show response

Murphy attributed the raise to below-the-line benefits rather than reduced marketing investment, addressing the premise.

Calendar 2026 Q1

Your top line growth was good, but your op margins contracted almost 10 points I know, John, you touched on this a bit

ChallengingMarginCost PressureTranscript · FY2026 Q1 →
Show response

John largely referred back to prior answer on China inventory phasing, acknowledged structural geographic mix headwind between Japan and developing markets.

Calendar 2025 Q3

I actually just had a quick question on your business in Asia

Geographic ExpansionPricingTranscript · FY2025 Q3 →
Show response

James explained APAC price/mix spike is a mix effect from lower-priced emerging markets (India, ASEAN) underperforming, making developed markets overweight. Not a real pricing change.

Calendar 2025 Q2

hoping you could just provide a little bit more color on sort of what drove that upside

MarginInnovation & R&DTranscript · FY2025 Q2 →
Show response

James cited two sources: marketing transformation delivering efficiency in ad production and media buying, and disciplined operating expense management capturing savings earlier than planned.

Calendar 2025 Q1

how your away from home business trended in the quarter

Show response

James noted IC held up better than take-home in US and Europe. Globally, away-from-home grew slightly faster. Weakness concentrated in developed market take-home.

Calendar 2024 Q4

how are you thinking about potential impacts on consumption from GLP-1 drugs. Have you seen any impact

Regulation PolicyDemandTranscript · FY2024 Q4 →
Show response

Management acknowledged anecdotal GLP-1 impact but noted it's not a big aggregate factor for beverage industry, citing 1% NA volume growth in Q4.

PGThe Procter & Gamble Company6 questions · 6 reporting periods · 2 of 6 challenging
PG company page →

Calendar 2026 Q2

I was hoping for a little more color on your business. In the market and then your expectations for category growth

Geographic ExpansionInnovation & R&DDemandTranscript · FY2026 Q4 →
Show response

Jejurikar answered only on the innovation bar and brand building multiplier; the China category growth outlook and share expectations were left to a later answer to Galbo.

Calendar 2026 Q1

I have a quick question on Baby Care, which appears to be turning following declines over the past year

DemandCompetitive DynamicsTranscript · FY2026 Q3 →
Show response

Andre confirmed Baby Care is growing share globally with 5 of 7 regions gaining. U.S. is the largest underperforming region and is receiving focused investment in product, communication, and trial.

Calendar 2025 Q4

could you provide a little more color I guess, on what drove the weakness on volumes

MarginInnovation & R&DTranscript · FY2026 Q2 →
Show response

Andre tied grooming softness to Braun/male/female initiative phasing; Shailesh cited Venus growth opportunity, appliances upside and US shelf redesign.

Calendar 2025 Q2

your ranges are quite a bit wider than they've been historically. Now I certainly recognize there's a fair amount

ChallengingGuidance ReliabilityTranscript · FY2025 Q4 →
Show response

Andre cited top-line uncertainty, tariff swings, pricing recovery timing and restructuring savings phasing, confirming back-half-weighted EPS.

Calendar 2025 Q1

based on your update, it still implies an acceleration in Q4 versus Q3. And then just, you know, thinking about that

ChallengingGuidance ReliabilityDemandTranscript · FY2025 Q3 →
Show response

Andre defended wide 0.5-4.5% Q4 range; inventory destock viewed as structural due to channel shift to club/online/big box.

Calendar 2024 Q4

curious how much flexibility you have to deliver on your EPS guidance range? And then in the context of that

Guidance ReliabilityMarginTranscript · FY2025 Q2 →
Show response

Jon committed to sustaining innovation spend even at the cost of modestly lower EPS, citing historical precedent.

ELEstée Lauder Companies (The)5 questions · 5 reporting periods · 1 of 5 challenging
EL company page →

Calendar 2026 Q1

how critical it is for organic sales growth acceleration to ultimately drive op margin improvement versus your PRGP savings

Show response

Akhil confirmed margin achievable across different sales scenarios given comprehensive cost transformation underway. Restructuring plus everyday efficiency building give confidence at different growth rates. Stephane updated on Travel Retail: low single-digit growth in Q3 with sequential improvement. Beijing/Shanghai airport retailer transition impact less than initially expected. Hainan grew over 30% in retail with 6 brands in double digit.

Calendar 2025 Q4

you expect growth to be flat in the year

ChallengingDemandGeographic ExpansionTranscript · FY2026 Q2 →
Show response

Stephane acknowledged ten years of Americas share loss but highlighted volume share gains in calendar 2025 across categories. Department store rebalancing ongoing while Amazon, specialty multi expanding. Latin America slowing on tariff-driven consumer confidence erosion. Q4 expected stronger than Q3. Full year Americas flat implies positive quarters from Q2 onward after negative Q1.

Calendar 2025 Q3

Could you provide just, I guess, a little more color on inventory levels and movements in the quarter?

Supply ChainDemandTranscript · FY2026 Q1 →
Show response

Stephane divided TR Asia: Japan double-digit growth, rest of APAC ex-China/Korea gaining share. China ecosystem TR inventory rightsized and managed to demand. Traffic turning positive in September with Hainan air traffic up 14%. Conversion still slightly down but improving with retail activations. Golden Week showed market share gains. Akhil confirmed inventory significantly lower than a year ago in both absolute terms and ratios.

Calendar 2025 Q1

do you see end market trends improving relative to the second half of this fiscal year? Or is it reasonable to assume similar trends persists

DemandGuidance ReliabilityTranscript · FY2025 Q3 →
Show response

Stéphane cited share gains in key markets, travel retail de-risking (down 10pts of mix), PRGP progress, and sequential net sales improvement. Acknowledged external risks including tariffs and consumer confidence.

Calendar 2024 Q3

could you give us a sense of maybe where retail inventory levels are currently maybe versus a year ago? And how much further destocking you expect

Supply ChainDemandTranscript · FY2025 Q1 →
Show response

Tracey confirmed inventory reduced but slower progress than expected due to market deceleration. Fabrizio added inventory is at lowest levels in years but market is also lower.

KMBKimberly-Clark5 questions · 5 reporting periods · 0 of 5 challenging
KMB company page →

Calendar 2026 Q2

could you unpack the drivers of this softness, including underlying consumption trends versus retailer destocking

Show response

Nelson broke out the 170 basis point shipment-consumption gap between the LA fire and retailer inventory movements, and Russ gave confidence in a second-half reacceleration.

Calendar 2025 Q4

do you need end market growth to improve to hit your mid-single to high-single digit EBIT growth guidance?

DemandGuidance ReliabilityTranscript · FY2025 Q4 →
Show response

Hsu and Torres explained volume growth driven by value proposition at every tier. North America Q4 vol+mix 1.7% (3.6% two-year stack). Category outlook ~2% globally implied in 2026 guidance.

Calendar 2025 Q2

how should we think about the organic sales growth and margin EPS accretion to your long-term algo?

Show response

Hsu emphasized consumption-driven growth, not shipment management. IFP transaction improves growth consistency with personal care categories slightly margin accretive. Path to 40% gross margin potentially faster than 2030.

Calendar 2025 Q1

I'm trying to bridge the gap between your new EPS guidance versus prior. So hoping you could maybe walk through the different puts and takes

Guidance ReliabilityTrade TariffsTranscript · FY2025 Q1 →
Show response

Urdaneta confirmed change boils down to $200M net tariff headwind. Q2 expected biggest impact with around 200 basis point headwind. SG&A savings providing some flexibility.

Calendar 2024 Q4

I was hoping to get some color on phasing this year. There are several moving parts, including the impact from potential retailer destocking

Revenue GrowthInventoryTranscript · FY2024 Q4 →
Show response

Urdaneta unpacked 2024 retail inventory reductions causing 60bps full-year sales impact and expected 40bps tailwind in 2025. Profits expected more evenly distributed.

TAPMolson Coors Beverage Company5 questions · 5 reporting periods · 2 of 5 challenging
TAP company page →

Calendar 2026 Q2

I'd be curious to hear from you what you're seeing in terms of category demand and really consumer behavior?

DemandCompetitive DynamicsTranscript · FY2026 Q2 →
Show response

Rahul detailed a Q2 consumer shift toward convenience/dollar channels and singles, and pointed to innovation (Keystone, Monaco, price pack architecture) as the response. Said the company gained incremental shelf space across core, Value and Above Premium brands in the spring resets.

Calendar 2025 Q3

why you believe it's cyclical versus structural?

ChallengingDemandMacroeconomicTranscript · FY2025 Q3 →
Show response

Rahul distinguished pre-2025 structural trends (health/wellness, generational change, ~-3% industry) from 2025 added pressure (tariffs, immigration, economic impacts on Hispanic community). Internal estimates show -4.7% industry in Q3. Believes return to pre-2025 levels once macro issues pass. Under-indexing in U.S. above premium is key opportunity.

Calendar 2025 Q2

how are you thinking about pricing for the remainder of the year? Also, what about the promotional environment?

PricingCompetitive DynamicsTranscript · FY2025 Q2 →
Show response

Gavin characterized summer promotional activity as typical and expected 1-2% annual net price increase in North America, in line with historical average. Noted consumer value-seeking is manifesting in channel and pack shifting, not segment trade down.

Calendar 2025 Q1

I assume your retained share that you've talked about in the past is now below the 80%. So if you could update us on that

ChallengingCompetitive DynamicsDemandTranscript · FY2025 Q1 →
Show response

Gavin confirmed core brands at 15.4 share vs 13.5 pre-step-change, retaining nearly all gains. Noted mid-March acceleration in share loss from Blue Moon pack shift and Simply Limeade cycling. April showed some industry improvement.

Calendar 2024 Q4

could you give us a little more color on the drivers of EPS growth, such as the cost savings and efficiencies you expect to get this year

MarginCost PressureTranscript · FY2024 Q4 →
Show response

Tracey cited brewery efficiencies, improved marketing ROI, Peroni onshore production freight savings, and divesting underperforming craft breweries as key operating leverage drivers.

CELHCelsius Holdings, Inc.4 questions · 4 reporting periods · 1 of 4 challenging
CELH company page →

Calendar 2026 Q2

do you believe ultimately this was the right decision? And maybe is there anything you would have done differently

ChallengingDemandCompetitive DynamicsGuidance ReliabilityTranscript · FY2026 Q2 →
Show response

CEO candidly admitted the SKU cut went too deep and he would have cut fewer SKUs; framed Q3 as a similar sidestep before Q4 improvement.

Calendar 2026 Q1

I guess I was hoping for some more color on the growth, which has been moderating.

Revenue GrowthDemandCompetitive DynamicsTranscript · FY2026 Q1 →
Show response

Herzog pressed on decelerating CELSIUS growth; management cited SKU optimization timing and fizz-free focus but did not quantify Alani cannibalization.

Calendar 2025 Q4

could you touch on the potential impact that the Midwest premium is having on your business near term?

MarginTrade TariffsTranscript · FY2025 Q4 →
Show response

Jarrod detailed the path from 47.4% back to low-50s gross margin (aligning Alani/Rockstar COGS, orbit/freight, mix; one-time Q4 scrap and write-offs gone), with mid-50s a multi-year target, and flagged Midwest premium and tariffs as the swing factors on timing.

Calendar 2025 Q3

I'm hoping for some more color on the puts and takes and how we should think about gross margins moving forward.

MarginTrade TariffsTranscript · FY2025 Q3 →
Show response

John and Jarrod detailed rising tariffs, Midwest premium pressure and integration savings offsets, with margin benefits building into first-half 2026.

BF-BBrown–Forman3 questions · 3 reporting periods · 2 of 3 challenging
BF-B company page →

Calendar 2025 Q3

shipments, as we've discussed, we're well ahead of depletions in Q1. As a result, this was certainly a benefit to organic sales in the quarter, but could you quantify for us the EBIT impact of that...

ChallengingInventoryPricingMarginTranscript · FY2026 Q1 →
Show response

Leanne directed to Schedule D for full P&L impact of shipment timing. Price/mix driven by higher growth of New Mix and lower used barrel sales, partially offset by Blackberry launch. Lawson corrected that the gross margin price/mix impact was 0.5%, not 5%.

Calendar 2025 Q1

I was hoping for a little bit more color on your marketing and advertising spend in the quarter, which was scaled back a little bit

Capex InvestmentCompetitive DynamicsTranscript · FY2025 Q3 →
Show response

Leanne tied ad spend to underlying depletion-based growth. Lawson confirmed restructuring savings will partly fund incremental brand investment in FY26, with more detail on June call.

Calendar 2024 Q4

I was actually hoping for a little bit more color on the divergence in trends between U.S. consumer takeaways and your reported whiskey depletions

ChallengingRevenue GrowthCompetitive DynamicsTranscript · FY2025 Q2 →
Show response

Lawson pushed back on the divergence thesis, saying organic sales and takeaway are converging around -3%. On-premise about 1 point weaker than off-premise.

KVUEKenvue3 questions · 3 reporting periods · 1 of 3 challenging
KVUE company page →

Calendar 2025 Q2

wondering if you've seen that pick up in Q3 so far? And if so, how much of a benefit do you see in Q3 as a result of this shift

DemandRevenue GrowthTranscript · FY2025 Q2 →
Show response

CFO confirmed July trends similar to Q2 with continued weak seasons. Softer comps expected in Q4 when lapping trade accruals and China weakness from prior year.

Calendar 2025 Q1

I wanted to drill down a little bit on some of the innovation plans that you have for the year and spending, just given the environment and the macro

Product LaunchMacroeconomicTranscript · FY2025 Q1 →
Show response

CEO confirmed innovation plans broadly unchanged. Augmenting with right entry price points and price pack architecture to respond to value-seeking consumers.

Calendar 2024 Q4

I actually had a question on your self-care segment margins, which contracted a lot in Q4 and for the full year

ChallengingMarginDemandTranscript · FY2024 Q4 →
Show response

CEO deflected somewhat by noting quarterly segment margin volatility and mix effects from pediatric pain decline, but confirmed overall operating margin was within guidance at 21.5%.

KDPKeurig Dr Pepper1 question · 1 reporting period · 0 of 1 challenging
KDP company page →

Calendar 2025 Q2

how should we think about the levers and maybe confidence you have to continue to hit your mid-single-digit long-term growth Algo without another acquisition

Revenue GrowthMarginTranscript · FY2025 Q2 →
Show response

Sudhanshu walked through segment growth roles: U.S. RB MSD, U.S. Coffee LSD, International HSD. Margin expansion from price, productivity, mix and overhead. Gross margin contracted but OI margin held.

Challenge rate by company

Every company this analyst questioned, most questions first. A company-level rate is shown from 3 questions; below that it is withheld.

CompanyQuestionsChallenge rate
PM Philip Morris International1513%2 of 15 questions
MO Altria1443%6 of 14 questions
CASY Casey's General Stores, Inc.119%1 of 11 questions
PEP PepsiCo933%3 of 9 questions
STZ Constellation Brands922%2 of 9 questions
CLX Clorox825%2 of 8 questions
CHD Church & Dwight729%2 of 7 questions
CL Colgate-Palmolive757%4 of 7 questions
MNST Monster Beverage714%1 of 7 questions
KO The Coca-Cola Company617%1 of 6 questions
  • PM
    Philip Morris International · 15 questions
    13%2 of 15 questions
  • MO
    Altria · 14 questions
    43%6 of 14 questions
  • CASY
    Casey's General Stores, Inc. · 11 questions
    9%1 of 11 questions
  • PEP
    PepsiCo · 9 questions
    33%3 of 9 questions
  • STZ
    Constellation Brands · 9 questions
    22%2 of 9 questions
  • CLX
    Clorox · 8 questions
    25%2 of 8 questions
  • CHD
    Church & Dwight · 7 questions
    29%2 of 7 questions
  • CL
    Colgate-Palmolive · 7 questions
    57%4 of 7 questions
  • MNST
    Monster Beverage · 7 questions
    14%1 of 7 questions
  • KO
    The Coca-Cola Company · 6 questions
    17%1 of 6 questions
Show all 18 companies
CompanyQuestionsChallenge rate
PG The Procter & Gamble Company633%2 of 6 questions
EL Estée Lauder Companies (The)520%1 of 5 questions
KMB Kimberly-Clark50%none of 5 questions
TAP Molson Coors Beverage Company540%2 of 5 questions
CELH Celsius Holdings, Inc.425%1 of 4 questions
BF-B Brown–Forman367%2 of 3 questions
KVUE Kenvue333%1 of 3 questions
KDP Keurig Dr Pepper1—Rate withheld: fewer than 3 questions
  • PG
    The Procter & Gamble Company · 6 questions
    33%2 of 6 questions
  • EL
    Estée Lauder Companies (The) · 5 questions
    20%1 of 5 questions
  • KMB
    Kimberly-Clark · 5 questions
    0%none of 5 questions
  • TAP
    Molson Coors Beverage Company · 5 questions
    40%2 of 5 questions
  • CELH
    Celsius Holdings, Inc. · 4 questions
    25%1 of 4 questions
  • BF-B
    Brown–Forman · 3 questions
    67%2 of 3 questions
  • KVUE
    Kenvue · 3 questions
    33%1 of 3 questions
  • KDP
    Keurig Dr Pepper · 1 question
    —rate withheld: under 3 questions

Activity by reporting period

Questions recorded for each calendar quarter that companies’ reporting periods map to (not the call date), with the challenge rate for that period. Periods inside the range with no questions are shown as “No questions recorded”.

Questions by calendar reporting period
Calendar periodQuestionsChallenge rateCompanies
2024 Q3333%1 of 3 questions3
2024 Q41921%4 of 19 questions15
2025 Q11735%6 of 17 questions15
2025 Q21833%6 of 18 questions15
2025 Q31926%5 of 19 questions14
2025 Q41631%5 of 16 questions13
2026 Q11429%4 of 14 questions11
2026 Q21613%2 of 16 questions14
2026 Q330%none of 3 questions3
  1. 2024 Q33 questions · challenge rate 33% (1 of 3 questions) · 3 companies
  2. 2024 Q419 questions · challenge rate 21% (4 of 19 questions) · 15 companies
  3. 2025 Q117 questions · challenge rate 35% (6 of 17 questions) · 15 companies
  4. 2025 Q218 questions · challenge rate 33% (6 of 18 questions) · 15 companies
  5. 2025 Q319 questions · challenge rate 26% (5 of 19 questions) · 14 companies
  6. 2025 Q416 questions · challenge rate 31% (5 of 16 questions) · 13 companies
  7. 2026 Q114 questions · challenge rate 29% (4 of 14 questions) · 11 companies
  8. 2026 Q216 questions · challenge rate 13% (2 of 16 questions) · 14 companies
  9. 2026 Q33 questions · challenge rate 0% (none of 3 questions) · 3 companies

Topics

Topics tagged on this analyst’s questions.

  • Demand44
  • Margin37
  • Guidance Reliability32
  • Competitive Dynamics31
  • Pricing23
  • Revenue Growth20
  • Product Launch12
  • Capex Investment9
  • Cost Pressure8
  • M&A7
Show all 18 topics
  • Macroeconomic7
  • Supply Chain7
  • Trade Tariffs6
  • Capital Allocation5
  • Geographic Expansion5
  • Regulation Policy4
  • Innovation & R&D3
  • Inventory3